These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25032097)

  • 1. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
    Khullar V; Dolganiuc A; Firpi RJ
    World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Patel YA; Berg CL; Moylan CA
    Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
    Kappus M; Abdelmalek M
    Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAFLD and liver transplantation: Current burden and expected challenges.
    Pais R; Barritt AS; Calmus Y; Scatton O; Runge T; Lebray P; Poynard T; Ratziu V; Conti F
    J Hepatol; 2016 Dec; 65(6):1245-1257. PubMed ID: 27486010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .
    Samji NS; Heda R; Satapathy SK
    Transl Gastroenterol Hepatol; 2020; 5():10. PubMed ID: 32190778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease after Liver Transplant.
    Shetty A; Giron F; Divatia MK; Ahmad MI; Kodali S; Victor D
    J Clin Transl Hepatol; 2021 Jun; 9(3):428-435. PubMed ID: 34221929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis: the new frontier for liver transplantation.
    Bzowej NH
    Curr Opin Organ Transplant; 2018 Apr; 23(2):169-174. PubMed ID: 29356708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.
    Shaker M; Tabbaa A; Albeldawi M; Alkhouri N
    World J Gastroenterol; 2014 May; 20(18):5320-30. PubMed ID: 24833862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to prevention of non-alcoholic fatty liver disease after liver transplantation.
    Sharma P; Arora A
    Transl Gastroenterol Hepatol; 2020; 5():51. PubMed ID: 33073046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.
    Lonardo A; Mantovani A; Petta S; Carraro A; Byrne CD; Targher G
    Nat Rev Endocrinol; 2022 Oct; 18(10):638-650. PubMed ID: 35840803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease.
    Kalogirou MS; Giouleme O
    World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
    Maliakkal BJ
    Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
    Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
    HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.